McDonald’s is changing its menu for the Ozempic era

With approximately 30 million Americans now using GLP-1 drugs, McDonald’s is adapting its menu to align with changing dietary preferences. These drugs, like Ozempic, are often used for weight management, prompting the fast-food giant to introduce smaller portions and more protein-rich options. New menu items include grilled chicken, wraps, and egg bites, reflecting a shift towards healthier choices. This move signifies McDonald’s effort to remain relevant in the evolving food landscape, catering to customers who are increasingly conscious of their health and nutrition. By offering these alternatives, McDonald’s aims to attract a broader audience and meet the demands of those seeking balanced meals, while still maintaining its appeal as a convenient dining option. QUESTION: How might McDonald’s new menu changes influence other fast-food chains in their approach to health-conscious consumers?